Factors Influencing Recurrence Rate and Survival of Patients with Colorectal Metastases after Liver Resection

Stefan Petrovski; Aleksandar Serafimov; Ljubica Adzi-Andov; Elena Joveva; Marija Karakolevska; Ilija Milev

doi:10.3889/oamjms.2023.11784

Authors

Stefan Petrovski Faculty of Medical Sciences, Goce Delcev University, Shtip, Macedonia; Clinical Hospital Shtip, Shtip, Macedonia
Aleksandar Serafimov Faculty of Medical Sciences, Goce Delcev University, Shtip, Macedonia; Clinical Hospital Shtip, Shtip, Macedonia https://orcid.org/0000-0003-3638-1397
Ljubica Adzi-Andov Faculty of Medical Sciences, Goce Delcev University, Shtip, Macedonia; Specialized Hospital for Gynecology and Obstetrics Dr. Organdziski, Shtip, Macedonia
Elena Joveva Faculty of Medical Sciences, Goce Delcev University, Shtip, Macedonia; Clinical Hospital Shtip, Shtip, Macedonia
Marija Karakolevska Faculty of Medical Sciences, Goce Delcev University, Shtip, Macedonia; Clinical Hospital Shtip, Shtip, Macedonia https://orcid.org/0000-0001-7353-2110
Ilija Milev Faculty of Medical Sciences, Goce Delcev University, Shtip, Macedonia; Clinical Hospital Shtip, Shtip, Macedonia https://orcid.org/0009-0005-0417-5101

DOI:

https://doi.org/10.3889/oamjms.2023.11784

Keywords:

colorectal carcinoma, liver metastases, survival, recurrence

Abstract

BACKGROUND: Early recurrence implies low percentage of long survival, whereas the opportunity for re-resection in selected patients represents optimal treatment with long survival. The total 5-year survival rate after hepatectomy is up to 50%, with a number of factors that are independent clinical predictors of long survival.

AIM: This study aims to analyze the patient’s data from the clinic of general and hepatobiliary surgery in Aleksandrovska Hospital in Sofia, Republic of Bulgaria, in the treatment of patients with colorectal metastases of the liver and to determine the survival factors in those patients.

MATERIALS AND METHODS: A retrospective study was conducted between of January 1st, 2006 and December 31st, 2015. A total of 239 patients were included: 179 patients were treated with radical operation, 5 with palliative intervention, while 55 operative explorations were performed.

RESULTS: The type and the extent of resection do not affect the occurrence of local recurrence. The size, number, and metastase localization do not affect the occurrence of intrahepatic recurrence but showed characteristics of significant predictors in cumulative and mean survival.

CONCLUSION: Metastases type, number and localization and metastases in lymphatic nodes and other organs were determined as predictors of long survival of patients with colorectal metastases after resection.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Tabchouri N, Gayet B, Okumura S, Donatelli G, Beaussier M, Bennamoun M, et al. Recurrence patterns after laparoscopic resection of colorectal liver metastases. Surg Endosc. 2018;32(12):4788-97. https://doi.org/10.1007/s00464-018-6229-6 PMid:29761279 DOI: https://doi.org/10.1007/s00464-018-6229-6

Inoue Y, Fujii K, Kagota S, Tomioka A, Yamaguchi T, Ohama H, et al. The management of recurrence within six months after hepatic resection for colorectal liver metastasis. Dig Surg. 2020;37(4):282-91. https://doi.org/10.1159/000503420 PMid:31597148 DOI: https://doi.org/10.1159/000503420

Plúa-Muñiz K, Bailón-Cuadrado M, Pérez-Saborido B, Pacheco- Sánchez D, Pinto P, Asensio-Díaz E. Survival analysis and identification of prognostic factors in colorectal liver metastasis after liver resection. Cir Esp (Engl Ed). 2023;101(3):160-9. https://doi.org/10.1016/j.cireng.2022.09.023 PMid:36108955 DOI: https://doi.org/10.1016/j.cireng.2022.09.023

Cucchetti A, Ferrero A, Cescon M, Donadon M, Russolillo N, Ercolani G, et al. Cure model survival analysis after hepatic resection for colorectal liver metastases. Ann Surg Oncol. 2015;22(6):1908-14. https://doi.org/10.1245/s10434-014-4234-0 PMid:25398280 DOI: https://doi.org/10.1245/s10434-014-4234-0

Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13(1):51-64. https://doi.org/10.1634/theoncologist.2007-0142 PMid:18245012 DOI: https://doi.org/10.1634/theoncologist.2007-0142

Rees M, Tekkis PP, Welsh FK, O’Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: A multifactorial model of 929 patients. Ann Surg. 2008;247(1):125-35. https://doi.org/10.1097/SLA.0b013e31815aa2c2 PMid:18156932 DOI: https://doi.org/10.1097/SLA.0b013e31815aa2c2

Lesurtel M, Selzner M, Petrowsky H, McCormack L, Clavien PA. How should transection of the liver be performed? A prospective randomized study in 100 consecutive patients: Comparing four different transection strategies. Ann Surg. 2005;242:814-22; discussion 822-3. https://doi.org/10.1097/01.sla.0000189121.35617.d7 PMid:16327491 DOI: https://doi.org/10.1097/01.sla.0000189121.35617.d7

Panettieri E, Kim BJ, Kawaguchi Y, Ardito F, Mele C, De Rose AM, et al. Survival by number and sites of resections of recurrence after first curative resection of colorectal liver metastases. J Gastrointest Surg. 2022;26(12):2503-11. https://doi.org/10.1007/s11605-022-05456-0 PMid:36127553 DOI: https://doi.org/10.1007/s11605-022-05456-0

Mishima K, Wakabayashi T, Fujiyama Y, Alomari M, Colella M, Wakabayashi G. Resection margin status in laparoscopic liver resection for colorectal liver metastases: Literature review and future perspectives. Minerva Surg. 2022;77(5):428-32. https://doi.org/10.23736/S2724-5691.22.09568-5 PMid:36331367 DOI: https://doi.org/10.23736/S2724-5691.22.09568-5

Kasai S, Ashida R, Sugiura T, Ohgi K, Yamada M, Otsuka S, et al. Long-term outcomes of staged liver resection for synchronous liver metastases from colorectal cancer and the clinical impact of early recurrence: A single-center retrospective cohort study. Ann Gastroenterol Surg. 2022;7(2):318-25. https://doi.org/10.1002/ags3.12628 PMid:36998298 DOI: https://doi.org/10.1002/ags3.12628

Viganò L, Gentile D, Galvanin J, Corleone P, Costa G, Cimino M, et al. Very early recurrence after liver resection for colorectal metastases: Incidence, risk factors, and prognostic impact. J Gastrointest Surg. 2022;26(3):570-82. https://doi.org/10.1007/s11605-021-05123-w PMid:34508293 DOI: https://doi.org/10.1007/s11605-021-05123-w

Palkovics A, Vereczkei A, Kalmár KN, Fincsur A, Kiss I, Németh B, et al. The issue of survival after colorectal liver metastasis surgery: Parenchyma sparing vs. Radicality. Anticancer Res. 2018;38(11):6431-8. https://doi.org/10.21873/anticanres.13004 PMid:30396968 DOI: https://doi.org/10.21873/anticanres.13004

Wong GY, Mol B, Bhimani N, de Reuver P, Diakos C, Molloy MP, et al. Recurrence patterns predict survival after resection of colorectal liver metastases. ANZ J Surg. 2022;92(9):2149-56. https://doi.org/10.1111/ans.17835 PMid:35666139 DOI: https://doi.org/10.1111/ans.17835

Reboux N, Jooste V, Goungounga J, Robaszkiewicz M, Nousbaum JB, Bouvier AM. Incidence and survival in synchronous and metachronous liver metastases from colorectal cancer. JAMA Netw Open. 2022;5(10):e2236666. https://doi.org/10.1001/jamanetworkopen.2022.36666 PMid:36239935 DOI: https://doi.org/10.1001/jamanetworkopen.2022.36666

Engstrand J, Strömberg C, Nilsson H, Freedman J, Jonas E. Synchronous and metachronous liver metastases in patients with colorectal cancer-towards a clinically relevant definition. World J Surg Oncol. 2019;17(1):228. https://doi.org/10.1186/s12957-019-1771-9 PMid:31878952 DOI: https://doi.org/10.1186/s12957-019-1771-9

Nakamoto T, Hokuto D, Nomi T, Yoshikawa T, Kamitani N, Matsuo Y, et al. Characteristics of 5-year survivors after liver resection for colorectal liver metastases in modern chemotherapy. Anticancer Res. 2020;40(2):1107-16. https://doi.org/10.21873/anticanres.14050 PMid:32014961 DOI: https://doi.org/10.21873/anticanres.14050

Ercolani G, Grazi GL, Ravaioli M, Cescon M, Gardini A, Varotti G, et al. Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch Surg. 2002;137(10):1187-92. https://doi.org/10.1001/archsurg.137.10.1187 PMid:12361432 DOI: https://doi.org/10.1001/archsurg.137.10.1187

Yoshimoto T, Morine Y, Imura S, Ikemoto T, Iwahashi S, Saito YU, et al. Maximum diameter and number of tumors as a new prognostic indicator of colorectal liver metastases. In Vivo. 2017;31(3):419-23. https://doi.org/10.21873/invivo.11076 PMid:28438872 DOI: https://doi.org/10.21873/invivo.11076

Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;25:4575-80. https://doi.org/10.1200/JCO.2007.11.0833 DOI: https://doi.org/10.1200/JCO.2007.11.0833

Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival. Ann Surg. 2004;240(4):644-57. https://doi.org/10.1097/01.sla.0000141198.92114.f6 PMid:15383792 DOI: https://doi.org/10.1097/01.sla.0000141198.92114.f6